AI assistant
Sending…
CONMED Corp — Director's Dealing 2016
Dec 9, 2016
31971_dirs_2016-12-09_8dd67196-b998-46e2-9a71-a39e19cc0518.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-12-08
Reporting Person: Berge Terence M (VP Corp. Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-08 | Common Stock | M | 2500 | $29.92 | Acquired | 18155 | Direct |
| 2016-12-08 | Common Stock | F | 1968 | $45.21 | Disposed | 16187 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-08 | Sars (Stock Appreciation Rights) | $29.92 | M | 2500 | Disposed | 2017-05-17 | Common Stock (2500) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7